FDA: Risks of new asthma drugs vary

Friday, December 5, 2008 - 18:42 in Health & Medicine

WASHINGTON (AP) -- The blockbuster asthma drug Advair does not appear to have an increased risk of serious respiratory complications seen with similar new medicines, federal health officials said Friday....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net